Ovarian cancer study identifies key genes for potential treatments
New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond better to treatment than others.
New collaboration to support more radiographers into research
Imperial College Academic Health Science Centre (AHSC) has been selected to set up an incubator to encourage more radiographers into research.
National award to increase research in children’s intensive care
Imperial College London has been awarded funding to set up an incubator to further develop research in Paediatric Critical Care.
Roaming portrait exhibition celebrates staff and patients in healthcare research
Imperial College Academic Health Science has launched a roving photography-led exhibition of patients and researchers involved in healthcare research.
Audio
Podcast: Credit rating inequalities, making mosquito music, and better batteries
In this edition: How AI has magnified credit disparities, how malaria research was translated into sound, and how batteries can make a better world.
1
Kisspeptin hormone injection could treat low sex drive in women and men
The hormone kisspeptin could be used to treat women and men distressed by their low sexual desire, according to two new studies.
COVID-19 treatments have long-term benefits for patients
Drugs used to treat critically ill COVID-19 patients in hospital have long-term benefits, according to new research.
New machine learning tool can help predict patients most at risk of COVID-19
Researchers have created a machine learning tool that can help identify patients who are most at risk of developing COVID-19 while in hospital.
Audio
Podcast: Smashing atoms at the LHC, becoming a medic, and finding Arctic bees
In this edition: We discover the latest science at the Large Hadron Collider, meet a medical student, and help the BBC find bees in Lapland.
£95 million investment for Imperial Biomedical Research Centre
Imperial College Healthcare NHS Trust and Imperial College London have been awarded more than £95 million to develop and improve care for patients.
